Company Insider Sells 1,000 Shares in $CFR

According to recent information obtained from an SEC filing, Bobby Berman, the GEVP Research & Strategy of $CFR, recently sold 1,000 shares of the company on January 30, 2026, for an estimated value of $137,070. This sale constitutes approximately 3.4% of their total shares in this class of stock, leaving them with 28,406 shares of $CFR stock in their possession.

When it comes to insider trading activity related to $CFR, insiders have engaged in trading activities on the open market three times within the past six months. Out of these transactions, there have been no purchases, only sales. Details of recent trading activities involving $CFR stock by insiders include Bobby Berman selling 1,000 shares for around $137,070, Coolidge E Jr Rhodes selling 700 shares for approximately $88,900, and Ericka Lynn Pullin, GEVP of Culture & People Dev., not making any sales within this timeframe.

In terms of hedge fund activity connected to $CFR, 221 institutional investors have added shares of $CFR stock to their portfolios, while 216 have decreased their positions in the most recent quarter. Some notable recent moves in this area include Westwood Holdings Group Inc adding 556,508 shares, equivalent to a 126.5% increase in their portfolio, during Q3 of 2025, with a total estimated value of $70,548,519. TWO SIGMA INVESTMENTS, LP added 356,373 shares (+2024.4%) to their portfolio in the same quarter, totaling $45,177,405. At the same time, Aristotle Capital Management, LLC reduced their holdings by 318,099 shares (-5.7%) in the third quarter of 2025, equating to an estimated value of $40,325,410.

For the revenue side of $CFR, the company reported revenues amounting to $1.1 billion in Q4 of 2025, indicating a significant uptick of 96.16% from the same period in the prior year. This financial data can be accessed and monitored on Quiver Quantitative’s CFR stock page for additional insights and analysis.

Regarding analyst ratings for $CFR, Wall Street analysts have recently issued reports on the stock. Notably, there have been zero buy ratings and one sell rating from firms within the last few months. For instance, Citigroup issued a “Sell” rating on October 31, 2025, reflecting one of the recent analyst ratings for $CFR.

Multiple analysts have also provided price targets for $CFR in recent times. Eight analysts have offered price targets for $CFR in the past six months, with a median target of $141.0. These targets come from various analysts like Catherine Mealor from Keefe, Bruyette & Woods setting a target price of $160.0 on January 30, 2026, and Jared Shaw from Barclays setting a target price of $150.0 on the same day. Jon G. Arfstrom from RBC Capital and Peter Winter from DA Davidson both set target prices at $150.0 and $144.0, respectively, on January 30, 2026, indicating a range of analyst opinions on the stock’s potential movement.